Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates consequent to loss of share certificates from the shareholder.
14-07-2022
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Please find enclosed herewith a certificate received from Universal Capital Securities Private Limited, Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2022.
11-07-2022
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates consequent to loss of share certificates from the shareholder.
11-07-2022
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has intimated regarding issue of duplicate share certificates to the shareholder of the Company.
06-07-2022
Bigul

BLISS GVS PHARMA LTD. - 506197 - Closure of Trading Window

This is to inform you that pursuant to Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force) and in accordance with the Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, the Trading window for dealing in securities/shares of Bliss GVS Pharma Limited ('the Company') will remain closed for Insiders, Designated Persons and their immediate relatives of the Company with effect from Friday, July 01, 2022 until 48 hours after the announcement of the Unaudited Financial Results of the Company for the quarter ended June 30, 2022.
30-06-2022
Bigul

BLISS GVS PHARMA LTD. - 506197 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Bliss GVS Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
30-06-2022
Bigul

BLISS GVS PHARMA LTD. - 506197 - Disclosure Of Voting Results Of The 37Th Annual General Meeting Of Bliss GVS Pharma Limited Held On June 28, 2022 Along With Scrutinizer'S Report

In accordance with the Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith the voting results of 37th Annual General Meeting of the Company held on Tuesday, June 28, 2022 in the prescribed format along with the report of the Scrutinizer on remote e-voting and e-voting at the 37th Annual General Meeting.
29-06-2022
Bigul

BLISS GVS PHARMA LTD. - 506197 - Disclosure Of Events Or Information - 37Th Annual General Meeting Held On Tuesday, June 28, 2022

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith proceedings of the 37th Annual General Meeting held on Tuesday, June 28, 2022 at 11:00 am through Video Conferencing ('VC')/Other Audio-Visual Means ('OAVM'). Kindly take the above intimation in your record.
28-06-2022
Bigul

BLISS GVS PHARMA LTD. - 506197 - Shareholder Meeting / Postal Ballot-Outcome of AGM

We would like to inform you that 37th Annual General Meeting of the Company was held today i.e. Tuesday, June 28, 2022 at 11:00 a.m., being requisite quorum present, meeting commenced at 11:00 a.m., through Video Conferencing ('VC')/Other Audio Visual Means ('OVAM") as attached herewith for your reference.
28-06-2022
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates consequent to loss of share certificates from the shareholder.
20-06-2022
Next Page
Close

Let's Open Free Demat Account